<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Garrett L</submitter><funding>German Center for Diabetes Research</funding><funding>Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH)</funding><funding>German federal ministerium of Education and Research</funding><pagination>331-350</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10290621</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(2)</volume><pubmed_abstract>Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic nervous system (ANS) and brain central autonomic network (CAN) interaction. This heart/brain inter-relationship harbors potentially novel NPD diagnosis and treatment avenues. Nevertheless, the lack of multidisciplinary clinical approaches as well as a limited appreciation of molecular underpinnings has stymied progress. Large-scale preclinical multi-systemic functional data can therefore provide supplementary insight into CAN and ANS interaction. We here present an overview of the heart/brain ax</pubmed_abstract><journal>Mammalian genome : official journal of the International Mammalian Genome Society</journal><pubmed_title>A rationale for considering heart/brain axis control in neuropsychiatric disease.</pubmed_title><pmcid>PMC10290621</pmcid><funding_grant_id>01KX1012</funding_grant_id><pubmed_authors>Hrabe de Angelis M</pubmed_authors><pubmed_authors>Garrett L</pubmed_authors><pubmed_authors>Holter SM</pubmed_authors><pubmed_authors>Fuchs H</pubmed_authors><pubmed_authors>Trumbach D</pubmed_authors><pubmed_authors>Wurst W</pubmed_authors><pubmed_authors>Spielmann N</pubmed_authors><pubmed_authors>Gailus-Durner V</pubmed_authors></additional><is_claimable>false</is_claimable><name>A rationale for considering heart/brain axis control in neuropsychiatric disease.</name><description>Neuropsychiatric diseases (NPD) represent a significant global disease burden necessitating innovative approaches to pathogenic understanding, biomarker identification and therapeutic strategy. Emerging evidence implicates heart/brain axis malfunction in NPD etiology, particularly via the autonomic nervous system (ANS) and brain central autonomic network (CAN) interaction. This heart/brain inter-relationship harbors potentially novel NPD diagnosis and treatment avenues. Nevertheless, the lack of multidisciplinary clinical approaches as well as a limited appreciation of molecular underpinnings has stymied progress. Large-scale preclinical multi-systemic functional data can therefore provide supplementary insight into CAN and ANS interaction. We here present an overview of the heart/brain ax</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2025-04-04T11:51:59.059Z</modification><creation>2025-04-04T11:51:59.059Z</creation></dates><accession>S-EPMC10290621</accession><cross_references><pubmed>36538124</pubmed><doi>10.1007/s00335-022-09974-9</doi></cross_references></HashMap>